FMP
Creative Medical Technology Holdings, Inc.
CELZ
NASDAQ
Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; StemSpine to treat chronic lower back pain; ImmCelz for the treatment of stroke patients; and OvaStem for treatment of female infertility. Creative Medical Technology Holdings, Inc. is based in Phoenix, Arizona.
4.81 USD
-0.1 (-2.08%)
About
ceo
Mr. Timothy Warbington
sector
Healthcare
industry
Biotechnology
website
https://www.creativemedicaltechnology.com
exchange
NASDAQ
Description
Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; StemSpine to treat chronic lower back pain; ImmCelz for the treatment of stroke patients; and OvaStem for treatment of female infertility. Creative Medical Technology Holdings, Inc. is based in Phoenix, Arizona.
CIK
0001187953
ISIN
US22529Y4089
CUSIP
22529Y200
Address
211 East Osborn Road
Phone
480 399 2822
Country
US
Employee
4
IPO Date
Nov 6, 2015
Summary
CIK
0001187953
Exchange
NASDAQ
Industry
Biotechnology
Sector
Healthcare
CUSIP
22529Y200
ISIN
US22529Y4089
Country
US
Price
4.81
Beta
5.04
Volume Avg.
209.93k
Market Cap
6.53M
Shares
-
52-Week
3.93-10.2812
DCF
2.45
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-1.28
P/B
-
Website
https://www.creativemedicaltechnology.com
Historical Prices
We are unable to load the chart at this time.
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
Upgrades and Downgrades
We are unable to load this data!
People Also Watch
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest CELZ News
It looks like there's no news available.
